Intestines-on-a-chip (gut-on-a-chip, mini-intestine) are microfluidic bioengineered 3D-models of the real organ, which better mimic physiological features than conventional 3D intestinal organoid culture. [1] A variety of different intestine-on-a-chip models systems have been developed and refined, all holding their individual strengths and weaknesses and collectively holding great promise to the ultimate goal of establishing these systems as reliable high-throughput platforms for drug testing and personalised medicine. The intestine is a highly complex organ system performing a diverse set of vital tasks, from nutrient digestion and absorption, hormone secretion, and immunological processes to neuronal activity, [2] which makes it particularly challenging to model in vitro.
Conventional intestinal models, such as traditional 2D cell culture of immortalised cell lines (e.g. CaCo2 or HT29), transwell cultures, Ussing chambers, and everted gut sacs, have been used extensively to understand better (patho-)physiological processes in the intestine. However, many intestinal functions are difficult to recapitulate and study using such simplistic models. Thus, these systems' translational and experimental value is limited. [3]
In 2009, the development of intestinal organoids [4] marked a milestone in the in vitro modelling of intestinal tissue. Intestinal organoids mimic the in vivo stem cell niche as intestinal stem cells spontaneously give rise to a closed, cystic mini-tissue with outward-facing buds representing the characteristic crypt-villus architecture of the intestinal epithelium. Intestinal organoids can contain all the different cell types of the intestinal epithelium, e.g. enterocytes, goblet cells, Paneth cells and enteroendocrine cells. [5] Together with the accurate representation of the tissue architecture and cell-type composition, organoids have been shown to also exhibit key functional similarities to the native tissue. [6] Furthermore, their long-term stability in culture, derivation from healthy and diseased origin and genetic manipulation possibilities make intestinal organoids a useful though simplistic model for large spread use as a platform for functional studies and disease modelling. [7]
Nevertheless, several limitations restrict their usefulness as an intestinal model. First and foremost, the organoids' closed cystic structure makes their inner (apical) surface inaccessible, and separate treatment of apical and basolateral sides — and thus transport studies — highly cumbersome. Moreover, this closed cystic structure implies that intestinal organoids accumulate shed dead cells in their lumen putting spatial strain on the organoids, thus impeding undisturbed organoid culture over longer periods of time without disruption by mechanical disruption and passaging. Furthermore, intestinal organoid cultures suffer from strongly variable sizes, shapes, morphologies and localisations between single organoids in their 3D culture environment. [8]
Although organoids usually are referred to as miniature organs, they lack vital features to mimic organ-level complexity. For this reason, biofabricated devices have been developed, which surpass organoid limitations. Especially microfluidic devices hold great potential as platforms for in vitro models of organs, as they enable perfusion mimicking the function of blood circulation in tissues. [1] [9] Apart from fluidic flow, other culture parameters are incorporated into intestine-on-a-chip devices, including architectural cues, mechanical stimulation, oxygen gradients and co-cultures with other cell populations and the microbiota, to more accurately display the physiological behaviour of the actual organ.[ citation needed ]
Opposite to traditional static cell culture, in microfluidic devices, fluid flows can be created, which closely mimick physiological fluid flow patterns. Fluid flow introduces physiological shear stress to cell surfaces, introduces apical delivery of nutrients and growth factors and enables the establishment of chemical gradients of, e.g. growth factors, which are vital for proper organ development. Overall, microfluidic devices increase the control over the organ-specific microenvironment, which allows for more precise models. [7]
Different technologies have been used to introduce microfluidic flows in intestine-on-a-chip devices, including peristaltic pumps, [10] syringe pumps, [11] pressure generators [12] and pumpless systems [13] driven by hydrostatic pressure and gravity. An example of a gravity-driven microfluidic intestine-on-a-chip device is the OrganoPlate platform by Mimetas, which has been used as a disease model for inflammatory bowel disease by Beaurivage et al. [14]
Beginning from the early stages of embryonic development up to the post-natal life, the intestine is constantly exposed to a wide range of mechanical forces. Peristalsis, the involuntary and cyclic propulsion of intestinal contents, is an essential part of the digestive process. It facilitates food digestion, nutrient absorption and intestinal emptying on a macro scale and applies shear stress and radial pressure on the intestinal epithelium on a micro-scale. [15] In particular, mechanical factors were shown to influence intestinal development and homeostasis, such as gut looping, [16] villi formation, [17] and crypt localisation. [18] Moreover, the chronic absence of mechanical stimuli in the human intestine has been associated with intestinal morbidity. [1]
A prominent example where both mechanical stimulations in the form of peristalsis and microfluidic flow are used in combination is the Emulate intestine-on-a-chip system. The system consists of a two-way central cell culture microchannel, which is separated by a porous, extracellular matrix-coated, PDMS membrane allowing the separate culture of two different cell populations in the upper and lower microchannel. The central chamber is enclosed by two vacuum chambers running in parallel. The application of vacuum allows the cyclic unidirectional expansion of the porous membrane separating the channels to mimic peristaltic motion [19]
As in traditional organoid culture, introducing a third culture dimension is critical for a better representation of the microanatomy of a tissue. Since 3D cell cultures implement more physiologically relevant biochemical and mechanical cues, 3D cultures generally achieve better cell viability and a more physiological transcriptome and proteome. Moreover, tissue homeostasis processes such as proliferation, differentiation and cell death are represented in a more physiological manner. [20] [21] The 3D support of cell cultures is commonly based on hydrogels, which mimick the native extracellular matrix. Cells can either be embedded into hydrogels or grown on a predefined micro-engineered hydrogel surface. [1] The most commonly used hydrogel for 3D intestinal systems is Matrigel, [22] a solubilised basement membrane extract from mouse sarcoma. However, Matrigel has significant disadvantages such as a xenogeneic origin, bath-to-batch variability, high cost and a poorly defined composition. As these factors hinder clinical translation, other hydrogels are increasingly used in 3D intestinal models, including fibrin, collagen, hyaluronic acid and PEG-based synthetic hydrogels. [23]
In tissue engineering, microfabrication techniques are of critical importance, especially in modelling the tissue microenvironment. Apart from designing and fabricating the microfluidic device itself, microfabrication techniques are also used to create 3D microstructures which allow the patterning of cell culture surfaces closely resembling the native tissue topography, i.e. the crypt-villus-axis. [1]
A prominent example of an intestine-on-a-chip system relying on architectural cues is the homeostatic mini-intestines by Nikolaev et al. [24] They use microfabricated intestine-on-a-chip devices with a hydrogel chamber. The collagen-Matrigel-mix hydrogel is laser-ablated to generate a microchannel for a tubular intestinal lumen with crypt structures. The culture of intestinal stem cells in this device results in their self-organisation into a functional epithelium with the physiological spatial arrangement of the crypt-villus domains. These mini-intestines allow for an extended long term culture and give rise to rare intestinal cell types not commonly found in other 3D models. Another example for architecturally driven morphogenesis of intestine-on-a-chip models are the surface patterning techniques published by Gjorevski et al., they developed microfabricated devices to pattern hydrogel surfaces in order to reproducibly direct intestinal organoid geometry, size and cell distributions. [25]
These examples show, that intestine-on-a-chip systems with extrinsically guided morphogenesis enable spatial and temporal control of signalling gradients and may provide a platform to extensively study intestinal morphogenesis, stem cell maintenance, crypt dynamics, and epithelial regeneration. [1]
The healthy intestine has a wide range of different functions, which requires a vast set of different cell types to fulfil them. The primary intestinal function, the absorption of nutrients, requires close contact between the intestinal epithelium and blood and lymph endothelial cells. Moreover, the intestinal microbiota plays a critical part in the digestion of food, which makes a reliable immune defence indispensable. Furthermore, muscle and nerve cells control peristalsis and satiety. Finally, mesenchymal cells are essential components of the intestinal stem cell niche as they provide physical support and secrete growth factors. Thus, incorporating different cell types in intestine-on-a-chip systems is vital to model different aspects of intestinal functions adequately. [1]
First steps were taken in co-culturing the intestinal epithelium and the microbiota in intestine-on-a-chip systems. Examples are the establishment of an in vitro model for intestinal Shigella flexneri infection using the Emulate intestine-on-a-chip system [26] or the recreation of a complex faeces-derived microbiota population with both aerobic and anaerobic species. [27] Similarly, researchers have tried to recreate an immunocompetent intestinal epithelium in intestine-on-a-chip systems, by co-culturing the intestinal epithelium with peripheral blood mononuclear cells, [28] monocytes, [29] macrophages [30] or neutrophils. [31] Moreover, the epithelial-endothelial interface has been modelled in several different systems by culturing endothelial monolayers and the intestinal epithelium on opposite sides of a porous membrane. [19] [27] [29] [32]
Apart from co-culturing intestinal cells with other cell types, also the cell population of the intestinal epithelium is of high relevance. While some rather simplistic approaches use immortalised cell lines as cell source for an intestinal epithelium, [14] there is a shift towards the use of organoid-derived intestinal stem cells, which allows the derivation of intestinal epithelia with a more physiological cell type composition. [1] [24] [32]
The large intestine, also known as the large bowel, is the last part of the gastrointestinal tract and of the digestive system in tetrapods. Water is absorbed here and the remaining waste material is stored in the rectum as feces before being removed by defecation. The colon is the longest portion of the large intestine, and the terms are often used interchangeably but most sources define the large intestine as the combination of the cecum, colon, rectum, and anal canal. Some other sources exclude the anal canal.
Gastrulation is the stage in the early embryonic development of most animals, during which the blastula, or in mammals the blastocyst, is reorganized into a two-layered or three-layered embryo known as the gastrula. Before gastrulation, the embryo is a continuous epithelial sheet of cells; by the end of gastrulation, the embryo has begun differentiation to establish distinct cell lineages, set up the basic axes of the body, and internalized one or more cell types including the prospective gut.
Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose, but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance, it can is considered as a field of its own.
Cell culture or tissue culture is the process by which cells are grown under controlled conditions, generally outside of their natural environment. After cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. They need to be kept at body temperature (37 °C) in an incubator. These conditions vary for each cell type, but generally consist of a suitable vessel with a substrate or rich medium that supplies the essential nutrients (amino acids, carbohydrates, vitamins, minerals), growth factors, hormones, and gases (CO2, O2), and regulates the physio-chemical environment (pH buffer, osmotic pressure, temperature). Most cells require a surface or an artificial substrate to form an adherent culture as a monolayer (one single-cell thick), whereas others can be grown free floating in a medium as a suspension culture. This is typically facilitated via use of a liquid, semi-solid, or solid growth medium, such as broth or agar. Tissue culture commonly refers to the culture of animal cells and tissues, with the more specific term plant tissue culture being used for plants. The lifespan of most cells is genetically determined, but some cell-culturing cells have been 'transformed' into immortal cells which will reproduce indefinitely if the optimal conditions are provided.
Gut-associated lymphoid tissue (GALT) is a component of the mucosa-associated lymphoid tissue (MALT) which works in the immune system to protect the body from invasion in the gut.
An organoid is a miniaturised and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural and biological complexity of that organ. They are derived from one or a few cells from a tissue, embryonic stem cells or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing organoids has rapidly improved since the early 2010s, and The Scientist names it as one of the biggest scientific advancements of 2013. Scientists and engineers use organoids to study development and disease in the laboratory, drug discovery and development in industry, personalized diagnostics and medicine, gene and cell therapies, tissue engineering and regenerative medicine.
In histology, an intestinal gland is a gland found in between villi in the intestinal epithelium lining of the small intestine and large intestine. The glands and intestinal villi are covered by epithelium, which contains multiple types of cells: enterocytes, goblet cells, enteroendocrine cells, cup cells, tuft cells, and at the base of the gland, Paneth cells and stem cells.
Ali Khademhosseini is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
The intestinal epithelium is the single cell layer that forms the luminal surface (lining) of both the small and large intestine (colon) of the gastrointestinal tract. Composed of simple columnar epithelium its main functions are absorption, and secretion. Useful substances are absorbed into the body, and the entry of harmful substances is restricted. Secretions include mucins, and peptides.
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture, integrated circuit (chip) that simulates the activities, mechanics and physiological response of an entire organ or an organ system. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context. By acting as a more sophisticated in vitro approximation of complex tissues than standard cell culture, they provide the potential as an alternative to animal models for drug development and toxin testing.
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments, a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 spheroids are usually cultured per bioreactor.
A neural, or brain organoid, describes an artificially grown, in vitro, tissue resembling parts of the human brain. Neural organoids are created by culturing pluripotent stem cells into a three-dimensional culture that can be maintained for years. The brain is an extremely complex system of heterogeneous tissues and consists of a diverse array of neurons and glial cells. This complexity has made studying the brain and understanding how it works a difficult task in neuroscience, especially when it comes to neurodevelopmental and neurodegenerative diseases. The purpose of creating an in vitro neurological model is to study these diseases in a more defined setting. This 3D model is free of many potential in vivo limitations. The varying physiology between human and other mammalian models limits the scope of animal studies in neurological disorders. Neural organoids contain several types of nerve cells and have anatomical features that recapitulate regions of the nervous system. Some neural organoids are most similar to neurons of the cortex. In some cases, the retina,spinal cord, thalamus and hippocampus. Other neural organoids are unguided and contain a diversity of neural and non-neural cells. Stem cells have the potential to grow into many different types of tissues, and their fate is dependent on many factors. Below is an image showing some of the chemical factors that can lead stem cells to differentiate into various neural tissues; a more in-depth table of generating specific organoid identity has been published. Similar techniques are used on stem cells used to grow cerebral organoids.
Muscle tissue engineering is a subset of the general field of tissue engineering, which studies the combined use of cells and scaffolds to design therapeutic tissue implants. Within the clinical setting, muscle tissue engineering involves the culturing of cells from the patient's own body or from a donor, development of muscle tissue with or without the use of scaffolds, then the insertion of functional muscle tissue into the patient's body. Ideally, this implantation results in full regeneration of function and aesthetic within the patient's body. Outside the clinical setting, muscle tissue engineering is involved in drug screening, hybrid mechanical muscle actuators, robotic devices, and the development of engineered meat as a new food source.
Microfluidic cell culture integrates knowledge from biology, biochemistry, engineering, and physics to develop devices and techniques for culturing, maintaining, analyzing, and experimenting with cells at the microscale. It merges microfluidics, a set of technologies used for the manipulation of small fluid volumes within artificially fabricated microsystems, and cell culture, which involves the maintenance and growth of cells in a controlled laboratory environment. Microfluidics has been used for cell biology studies as the dimensions of the microfluidic channels are well suited for the physical scale of cells. For example, eukaryotic cells have linear dimensions between 10 and 100 μm which falls within the range of microfluidic dimensions. A key component of microfluidic cell culture is being able to mimic the cell microenvironment which includes soluble factors that regulate cell structure, function, behavior, and growth. Another important component for the devices is the ability to produce stable gradients that are present in vivo as these gradients play a significant role in understanding chemotactic, durotactic, and haptotactic effects on cells.
Air liquid interface cell culture (ALI) is a method of cell culture by which basal stem cells are grown with their basal surfaces in contact with media, and the top of the cellular layer is exposed to the air. The cells are then lifted and media is changed until the development of a mucociliary phenotype of a pseudostratified epithelium, similar to the tracheal epithelium.
Open microfluidics can be employed in the multidimensional culturing of cell types for various applications including organ-on-a-chip studies, oxygen-driven reactions, neurodegeneration, cell migration, and other cellular pathways.
Cultrex Basement Membrane Extract (BME) is the trade name for a extracellular protein mixture secreted by Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells and manufactured into a hydrogel by R&D Systems, a brand of Bio-Techne. Similar to Matrigel, this hydrogel is a natural extracellular matrix that mimics the complex extracellular environment within complex tissues. It is used as a general cell culture substrate across a wide variety of research applications.
Matthias Lutolf is a bio-engineer and a professor at EPFL where he leads the Laboratory of Stem Cell Bioengineering. He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models. In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.
Experimental models of Alzheimer's disease are organism or cellular models used in research to investigate biological questions about Alzheimer's disease as well as develop and test novel therapeutic treatments. Alzheimer's disease is a progressive neurodegenerative disorder associated with aging, which occurs both sporadically or due to familial passed mutations in genes associated with Alzheimer's pathology. Common symptoms associated with Alzheimer's disease include: memory loss, confusion, and mood changes.
An assembloid is an in vitro model that combines two or more organoids, spheroids, or cultured cell types to recapitulate structural and functional properties of an organ. They are typically derived from induced pluripotent stem cells. Assembloids have been used to study cell migration, neural circuit assembly, neuro-immune interactions, metastasis, and other complex tissue processes. The term "assembloid" was coined by Sergiu P. Pașca's lab in 2017.
{{cite book}}
: CS1 maint: others (link)